Korean J Nephrol.  2011 May;30(3):343-345.

A Case of Delftia acidovorans Peritonitis in a Peritoneal Dialysis Patient Managed with Preserving the Dialysis Catheter

Affiliations
  • 1Eulji University, College of Medicine, Department of Internal Medicine, Divison of Nephrology, Eulji general hospital, Seoul, Korea. ondahl@eulji.ac.kr
  • 2Department of Laboratory Medicine, Eulji General hospital, Eulji University, College of Medicine, Seoul, Korea.

Abstract

Delftia acidovarans is aerobic, nonfermentative Gram-negative rod commonly found in soil and water. Generally it is nonpathogenic but it unusually can cause bacteremia in immunocompromised patients. We present a case of peritonitis due to D. acidovorans in a patient on continuous ambulatory peritoneal dialysis. A 75-year-old woman was admitted with abdominal pain and cloudy peritoneal effluent. She was empirically treated with intraperitoneal (IP) cefazolin and ceftazidime, and then IP ceftazidime and oral ciprofloxacin, but peritonitis did not improve. Seven days after admission, D. acidovorans was identified from the peritoneal effluent, which was sensitive to amikacin, ceftazidime, ciprofloxacin and imipenem. Catheter removal was considered with regard to poor response to adequate antibiotics; however, 4 days after changing to IP imipenem/cilastatin, abdominal pain, the leukocyte count of peritoneal effluent and C-reactive protein decreased. She was treated with imipenem/cilastatin for two weeks and discharged with the dialysis catheter intact.

Keyword

Delftia acidovorans; Peritonitis; Peritoneal dialysis

MeSH Terms

Abdominal Pain
Aged
Amikacin
Bacteremia
C-Reactive Protein
Catheters
Cefazolin
Ceftazidime
Ciprofloxacin
Delftia
Delftia acidovorans
Dialysis
Female
Humans
Imipenem
Immunocompromised Host
Leukocyte Count
Peritoneal Dialysis
Peritoneal Dialysis, Continuous Ambulatory
Peritonitis
Soil
Amikacin
C-Reactive Protein
Cefazolin
Ceftazidime
Ciprofloxacin
Imipenem
Soil
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr